PHOENIX -- For chronic or subacute subdural hematoma, embolization of the middle meningeal artery (MMA) reduced recurrence, three randomized trials showed. Two trials with the Onyx liquid embolic ...
The Onyx Liquid Embolic System (Medtronic) effectively occludes cerebral arteriovenous malformations (cAVMs), new observational data suggest. In a prospective, real-world study of more than 100 ...
Medtronic has announced the first subject enrolment in the Peripheral Onyx Liquid Embolic (PELE) trial. The study aims to assess the effectiveness and safety of Onyx's liquid embolic system (LES) for ...
PHOENIX, AZ—Middle meningeal artery (MMA) embolization with liquid agents looks set to become the standard of care for the treatment of nonacute subdural hematoma after three randomized trials ...
Subdural hematoma with mild symptoms progressed significantly less often when treated with middle meningeal artery (MMA) embolization compared with observation alone, new results from the second phase ...
Doctors at the Department of Neurosurgery, K.A.P. Viswanatham Government Medical College, attached to Mahatma Gandhi Memorial Government Hospital (MGMGH) in Tiruchi, recently treated a man suffering ...
Assistant Professor Jesse Jones, M.D., has been tapped by Medtronic to lead UAB in a clinical trial aimed at treating subdural hematomas. The study is titled “ Embolization of the Middle Meningeal ...
Type 2 endoleaks (T2E) occur in 10 to 20% of patients after endovascular abdominal aortic aneurysm repair (EVAR) and remain a significant clinical issue. To evaluate the efficacy and clinical outcomes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results